NCT00068107View on ClinicalTrials.gov

Dosing Study of Replagal in Patients With Fabry Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Fabry Disease
Interventions
DRUG

Replagal

enzyme replacement therapy

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

Sponsors
All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Baylor Research Institute

OTHER